ADL
VIR icon

Asset Dedication LLC’s Vir Biotechnology VIR Stock Holding History

Asset Dedication LLC’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$4K – 1040
2021
Q3 		$4K Buy
+100
New +$4.33K ﹤0.01% 843
2021
Q2 		– Sell
-108
Closed -$6K – 878
2021
Q1 		$6K Sell
108
-292
-73% -$15.7K ﹤0.01% 550
2020
Q4 		$11K Buy
+400
New +$13K ﹤0.01% 549

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Asset Dedication LLC's VIR Position: Q4 2021 in Review

Asset Dedication LLC sold out of Vir Biotechnology (VIR) in Q4 2021, closing a stake of 100 shares — an estimated $4K sold.

Asset Dedication LLC first reported a position in VIR in Q4 2020 and held it in 3 quarters. The position peaked at $11K in Q4 2020. 210 funds tracked by Wall St. Rank hold VIR as of Q4 2021.

  • Asset Dedication LLC reported no remaining Vir Biotechnology position as of Q4 2021 after selling out during the quarter.
  • Asset Dedication LLC sold 100 Vir Biotechnology shares in Q4 2021, an estimated $4K.
  • Asset Dedication LLC first reported a position in Vir Biotechnology in Q4 2020 and held it in 3 quarters.
  • Asset Dedication LLC's Vir Biotechnology position peaked at $11K in Q4 2020.
  • 210 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2021.

Based on Asset Dedication LLC's 13F filing for Q4 2021, filed 21 Jan 2022.